Evidence map›Paper›PMID 21559529›Full record

ArticlePloS one2011

Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features.

Delphine M Saulnier, Filipe Santos, Stefan Roos, Toni-Ann Mistretta, Jennifer K Spinler, Douwe Molenaar, Bas Teusink, James Versalovic

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Microbial lysate upregulates host oxytocin.Brain, behavior, and immunity · 2017
    Trial
  4. Trial
  5. Trial
  6. Revised complete genome sequences ofMicrobiology spectrum · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Probiotic Dairy Innovations: Exploring Buffalo Milk Potential for Food Product Development.Comprehensive reviews in food science and food safety · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine- and enterocyte-derived hormones.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  15. Development of aApplied and environmental microbiology · 2024
    Article
  16. bioRxiv : the preprint server for biology · 2024
    Article
  17. Nutrients · 2024
    Article
  18. Brain trust.Comprehensive psychoneuroendocrinology · 2023
    Review
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Delphine M SaulnierDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, United States of America. Delphine.Saulnier@nizo.nl
Filipe Santos
Stefan Roos
Toni-Ann Mistretta
Jennifer K Spinler
Douwe Molenaar
Bas Teusink
James Versalovic
Baylor College of Medicine · USCancer Genomics Centre · NLSwedish University of Agricultural Sciences · SE

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Modulation of NF-kB Signaling by ImmunoprobioticsR01AT004326 · NCCIH · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2008 to 2011
$1.8M
Intestinal Lactobacillus and Mucosal ImmunomodulationR01DK065075 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2007 to 2010
$1.3M
Probiotic Lactobacillus-Mediated Suppression of TNF in Pediatric Crohn's DiseaseR21AT003482 · NCCIH · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2007 to 2008
$408k
NCCIH NIH HHS R01 AT004326NCCIH NIH HHS R21 AT003482NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK56338NIDDK NIH HHS R01 DK065075
6 · The paper itself

Abstract

The genomes of four Lactobacillus reuteri strains isolated from human breast milk and the gastrointestinal tract have been recently sequenced as part of the Human Microbiome Project. Preliminary genome comparisons suggested that these strains belong to two different clades, previously shown to differ with respect to antimicrobial production, biofilm formation, and immunomodulation. To explain possible mechanisms of survival in the host and probiosis, we completed a detailed genomic comparison of two breast milk-derived isolates representative of each group: an established probiotic strain (L. reuteri ATCC 55730) and a strain with promising probiotic features (L. reuteri ATCC PTA 6475). Transcriptomes of L. reuteri strains in different growth phases were monitored using strain-specific microarrays, and compared using a pan-metabolic model representing all known metabolic reactions present in these strains. Both strains contained candidate genes involved in the survival and persistence in the gut such as mucus-binding proteins and enzymes scavenging reactive oxygen species. A large operon predicted to encode the synthesis of an exopolysaccharide was identified in strain 55730. Both strains were predicted to produce health-promoting factors, including antimicrobial agents and vitamins (folate, vitamin B(12)). Additionally, a complete pathway for thiamine biosynthesis was predicted in strain 55730 for the first time in this species. Candidate genes responsible for immunomodulatory properties of each strain were identified by transcriptomic comparisons. The production of bioactive metabolites by human-derived probiotics may be predicted using metabolic modeling and transcriptomics. Such strategies may facilitate selection and optimization of probiotics for health promotion, disease prevention and amelioration.

Indexed as

Gene Expression Regulation, BacterialGenome, BacterialBacterial AdhesionBiofilmsGene Expression ProfilingHumansLimosilactobacillus reuteriMetabolic Networks and PathwaysMilk, HumanMultigene FamilyPolysaccharidesProbioticsSpecies SpecificityTranscriptomePolysaccharides

Identifiers

PMID21559529
PMCPMC3084715
OpenAlexW2150636980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.